Fundz
New|Fundz now works inside Claude2 min

Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.

Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Vir Biotechnology Appoints David Liu as Chief Medical Officer

PUBLIC · VIROct 07, 2026

Position

Executive Vice President

Company

Vir Biotechnology, Inc.

David Liu
San FranciscoBiotechnology

Description

Vir Biotechnology, Inc. has appointed David Liu, M.D., Ph.D., as Executive Vice President and Chief Medical Officer. This appointment is effective October 12, 2026, where Dr

Company Information

Company

Vir Biotechnology, Inc.

Location

499 ILLINOIS STREET

San Francisco, California, United States

About

Vir Biotechnology brings together cutting-edge innovations with scientific expertise and management.

Fundz sees it the moment Vir Biotechnology, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jennifer
Likely contact at this company
••••••••@••••••••

See Jennifer's verified email →

Jason
Likely contact at this company
••••••••@••••••••

See Jason's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Vir Biotechnology, Inc.'s next move

Learn about Strategic plan

Vir Biotechnology, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.